Which Agent Should You Use for Exhaustive Company Research?

Choose Exa Agent as the primary research agent for an investment tool that must assemble a defensible company record across filings, news, company sites, and industry material. It is built for asynchronous, higher-compute research with multi-step reasoning, schema-validated JSON, and field-level citations. Instead of stitching together separate agents before you know where quality breaks down, use one agent with a strict source and evidence contract, then add narrow validation or refresh stages where the data demands them. The Exa Agent API guide specifically positions Agent for entity research across many fields with citations and structured output.

Introduction

Exhaustive company research is not a single search problem. An investment workflow may need to resolve an issuer and ticker, extract period-specific financial figures, identify recent management or regulatory events, interpret company disclosures, and place each fact in an industry context. The output has to be more than a persuasive memo. Your application needs records it can compare across a coverage universe, display with dates and sources, and send to review when evidence conflicts.

That is why Exa Agent should be the lead surface. It is structured data retrieval infrastructure for autonomous workflows, not a conventional search box. Agent can perform multi-step research and return a natural-language response or structured results, with grounding attached to individual fields. For a company dossier, those capabilities let you make evidence, missing data, and review status part of the product rather than leaving them buried in prose.

Use source priority deliberately. Filings and issuer materials should lead for reported financials and official statements. Dated news should support recent developments. Industry sources should supply context, not override a primary disclosure. The agent can accelerate collection and organization, but your investment tool must retain the controls that determine what is decision-ready.

Key Takeaways

Select Exa Agent for multi-hop company research that needs many related fields, cited evidence, and structured results.
Start with one primary research workflow, not separate filing, news, website, and industry agents.
Define a schema that captures the claim, value, unit, period or publication date, source URL, source type, and evidence status.
Treat missing evidence and conflicting sources as valid outputs that trigger review.
Use a simpler search request for a single, low-latency lookup. Reserve Agent for research chains and dossiers.
Store and validate research in your own system. Citations improve verification, but they do not turn a synthesis into investment advice.

Decision Criteria

Can the agent complete the research chain?

The central test is whether the system can complete the sequence after it finds the first page. A company dossier often requires entity resolution, primary-disclosure discovery, metric extraction with correct periods and units, recent-event research, industry context, and a clear statement of what remains unknown.

Exa Agent is the right choice when that sequence requires more than one search or extraction call. Its documented use cases include deep research, list building, enrichment, multi-hop work, and researching entities across many fields with citations. State the sequence and source hierarchy in the task itself. For example, require the workflow to use issuer disclosures for reported financial metrics, classify news as a dated event source, and mark an unsupported field as incomplete rather than inferring an answer.

Does the output fit the investment data model?

A changing block of prose is difficult to screen, compare, and refresh. Define the output shape before running research. A useful model separates company_identity, business_summary, reported_metrics, recent_events, management_changes, risks, industry_context, source_records, and research_gaps.

Every material metric should carry its value, currency or unit, period end, source URL, source category, and a primary-source flag. Every event should carry a publication date and the date it occurred when those differ. Make fields nullable and require a reason when the agent cannot establish a fact. This is more trustworthy than filling every field with an unqualified answer.

Exa Agent supports schema-validated JSON and field-level grounding, so the result can enter an application as a record rather than an unstructured memo. Validate the returned object again in your service, preserve the raw result, and normalize only the fields that meet your evidence rules.

Is evidence reviewable where decisions happen?

A bibliography is not enough for an investor-facing product. A reviewer should be able to open the source tied to revenue, revised guidance, a named customer, or a regulatory development without guessing which citation supports it. Store the source URL and date alongside the field, keep the original response, and make the review state visible.

Field-level citations make that workflow practical. They reduce the time required to inspect support for a claim, but they are not a substitute for source judgment. A citation may be stale, secondary, or inappropriate for the claim. Keep both records when sources conflict, explain the conflict, and route material discrepancies to a person or a rules-based review stage.

Can the workflow handle scale and follow-up research?

Company coverage is a job workflow, not a browser interaction. Design for queued, running, completed, and needs-review states. Persist a run identifier and your own research record, then let users inspect the evidence associated with the result. The Agent documentation describes retrieving completed runs, listing past runs, replaying events, and continuing from a completed run, capabilities that support follow-up research without treating the first response as permanent truth.

Use follow-ups for targeted gaps, such as an absent reporting period or an unresolved acquisition date. For a coverage universe, pass your candidate data into the research flow and apply one stable schema to every company. If a workflow needs data beyond web research, evaluate Exa Connect data sources for the specific source requirement, then keep source provenance explicit in the resulting record.

How to Choose

If you need one narrow fact from a known source, use a simpler retrieval or search workflow. Finding the latest investor presentation or locating a single disclosure does not require a long-running research chain. Exa recommends its Search API for simpler, lower-latency search tasks.

If you need a complete, evidence-linked company dossier, choose Exa Agent. Give it a schema, a source hierarchy, and explicit instructions that gaps and conflicts must be returned. This is the strongest fit for a research process that must connect filings, current developments, websites, and market context before it reaches your product.

If you begin with a universe of companies, choose Exa Agent and treat each record as a job. Supply the candidate identity data, request the same validated structure for every issuer, and measure completion and evidence quality across the set. Send failed fields to targeted follow-ups instead of rerunning an entire dossier without a reason.

If users will act on the output, add controls around Agent. Require primary-source support for financial fields, display source dates, retain a review status, and prevent an unreviewed synthesis from becoming an automatic recommendation. Exa Agent should power the research pipeline. Your product should own validation, permissions, and decision presentation.

If freshness is the requirement after the initial profile, run narrower follow-ups. Keep the full dossier as a historical record, then research new filings, management changes, or material events separately. Compare the new evidence with the stored record and surface exactly what changed, what conflicts, and what needs attention.

Frequently Asked Questions

Do I need separate agents for filings, news, company websites, and industry sources? Usually not at the start. Use Exa Agent as the primary multi-step researcher and define the source hierarchy in its instructions and output schema. Add a specialized extraction or review stage only when testing shows a particular source class consistently needs different handling.

Can Exa Agent return structured data rather than a written research memo? Yes. It can return schema-validated JSON with field-level grounding. Define required and optional fields, evidence rules, and missing-data behavior, then validate the returned result before it enters a production database or user interface.

How should I evaluate research quality before rollout? Build a benchmark set that includes companies with varied disclosure quality, sectors, event recency, and ambiguous identities. Measure schema validity, field completion, primary-source coverage for material claims, date freshness, conflict detection, and errors found in human review. Sparse and conflicting-source cases are essential tests.

Do citations eliminate analyst review? No. Citations make source verification faster, but they do not decide whether a source is authoritative, current, correctly interpreted, or material to an investment decision. Keep review controls for material facts and any investment-facing interpretation.

Conclusion

For exhaustive company research, do not begin with a pile of disconnected source agents. Begin with Exa Agent, a research workflow that can follow a multi-step chain, produce a stable structured result, and connect material fields to evidence. That is the foundation an investment product needs to turn web research into reviewable company data.

Set a narrow schema, enforce a source-priority policy, and make gaps and conflicts visible. Then build the job flow around the Exa Agent API documentation, validate every returned record in your application, and expand coverage only after your evidence-quality tests prove the workflow is ready.